Works matching IS 00302414 AND DT 2021 AND VI 99 AND IP 3
Results: 8
Front & Back Matter.
- Published in:
- Oncology, 2021, v. 99, n. 3, p. 1, doi. 10.1159/000515482
- Publication type:
- Article
Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World Experience.
- Published in:
- Oncology, 2021, v. 99, n. 3, p. 192, doi. 10.1159/000512000
- By:
- Publication type:
- Article
Molecular Biomarkers according to Primary Tumor Location in Colorectal Cancer: Current Standard and New Insights.
- Published in:
- Oncology, 2021, v. 99, n. 3, p. 135, doi. 10.1159/000510944
- By:
- Publication type:
- Article
Lenvatinib-Induced Tumor-Related Hemorrhages in Patients with Large Hepatocellular Carcinomas.
- Published in:
- Oncology, 2021, v. 99, n. 3, p. 186, doi. 10.1159/000510911
- By:
- Publication type:
- Article
TKTL1 as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma and Its Correlation with FDG-PET-CT.
- Published in:
- Oncology, 2021, v. 99, n. 3, p. 177, doi. 10.1159/000510862
- By:
- Publication type:
- Article
Potential and Clinical Significance of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment.
- Published in:
- Oncology, 2021, v. 99, n. 3, p. 169, doi. 10.1159/000510754
- By:
- Publication type:
- Article
Irinotecan and Gemcitabine as Second-Line Treatment in Patients with Malignant Pleural Mesothelioma following Platinum plus Pemetrexed Chemotherapy: A Retrospective Study.
- Published in:
- Oncology, 2021, v. 99, n. 3, p. 161, doi. 10.1159/000510691
- By:
- Publication type:
- Article
High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
- Published in:
- Oncology, 2021, v. 99, n. 3, p. 144, doi. 10.1159/000510609
- By:
- Publication type:
- Article